Matches in SemOpenAlex for { <https://semopenalex.org/work/W2110379660> ?p ?o ?g. }
- W2110379660 endingPage "51" @default.
- W2110379660 startingPage "51" @default.
- W2110379660 abstract "Cognitive impairment in late-life depression is a core feature of the illness.To test whether donepezil hydrochloride and antidepressant therapy is superior to placebo and antidepressant therapy in improving cognitive performance and instrumental activities of daily living and in reducing recurrences of depression over 2 years of maintenance treatment.Randomized, double-blind, placebo-controlled maintenance trial.University clinic.One hundred thirty older adults aged 65 years and older with recently remitted major depression.Random assignment to maintenance antidepressant pharmacotherapy and donepezil or to maintenance antidepressant pharmacotherapy and placebo.Global neuropsychological performance, cognitive instrumental activities of daily living, and recurrent depression.Donepezil and antidepressant therapy temporarily improved global cognition (treatment × time interaction, F₂,₂₁₆ = 3.78; P = .03), but effect sizes were small (Cohen d = 0.27, group difference at 1 year). A marginal benefit to cognitive instrumental activities of daily living was also observed (treatment × time interaction, F₂,₁₃₇ = 2.94; P = .06). The donepezil group was more likely than the placebo group to experience recurrent major depression (35% [95% confidence interval {CI}, 24%-46%] vs 19% [95% CI, 9%-29%], respectively; log-rank χ² = 3.97; P = .05; hazard ratio = 2.09 [95% CI, 1.00-4.41]). Post hoc subgroup analyses showed that of 57 participants with mild cognitive impairment, 3 of 30 participants (10% [95% CI, 0%-21%]) receiving donepezil and 9 of 27 participants (33% [95% CI, 16%-51%]) receiving placebo had a conversion to dementia over 2 years (Fisher exact test, P = .05). The mild cognitive impairment subgroup had recurrence rates of major depression of 44% with donepezil vs 12% with placebo (likelihood ratio = 4.91; P = .03). The subgroup with normal cognition (n = 73) showed no benefit with donepezil and no increase in recurrence of major depression.Whether a cholinesterase inhibitor should be used as augmentation in the maintenance treatment of late-life depression depends on a careful weighing of risks and benefits in those with mild cognitive impairment. In cognitively intact patients, donepezil appears to have no clear benefit for preventing progression to mild cognitive impairment or dementia or for preventing recurrence of depression.clinicaltrials.gov Identifier: NCT00177671." @default.
- W2110379660 created "2016-06-24" @default.
- W2110379660 creator A5000921316 @default.
- W2110379660 creator A5002128677 @default.
- W2110379660 creator A5004819487 @default.
- W2110379660 creator A5010114260 @default.
- W2110379660 creator A5019562259 @default.
- W2110379660 creator A5034902188 @default.
- W2110379660 creator A5036815556 @default.
- W2110379660 creator A5045976176 @default.
- W2110379660 creator A5047160700 @default.
- W2110379660 creator A5051629477 @default.
- W2110379660 creator A5053095971 @default.
- W2110379660 creator A5055361170 @default.
- W2110379660 creator A5064264687 @default.
- W2110379660 creator A5067826976 @default.
- W2110379660 creator A5069633657 @default.
- W2110379660 creator A5076904256 @default.
- W2110379660 creator A5080056025 @default.
- W2110379660 creator A5081567576 @default.
- W2110379660 creator A5082479521 @default.
- W2110379660 creator A5082886161 @default.
- W2110379660 creator A5085696063 @default.
- W2110379660 creator A5088728325 @default.
- W2110379660 creator A5091091899 @default.
- W2110379660 date "2011-01-03" @default.
- W2110379660 modified "2023-09-25" @default.
- W2110379660 title "Maintenance Treatment of Depression in Old Age" @default.
- W2110379660 cites W1847168837 @default.
- W2110379660 cites W1895538680 @default.
- W2110379660 cites W1966714873 @default.
- W2110379660 cites W1969010498 @default.
- W2110379660 cites W1972125775 @default.
- W2110379660 cites W1972370700 @default.
- W2110379660 cites W1979300931 @default.
- W2110379660 cites W1983925295 @default.
- W2110379660 cites W1986641829 @default.
- W2110379660 cites W1996147546 @default.
- W2110379660 cites W2008739372 @default.
- W2110379660 cites W2012202426 @default.
- W2110379660 cites W2022070083 @default.
- W2110379660 cites W2032393864 @default.
- W2110379660 cites W2040836716 @default.
- W2110379660 cites W2056272943 @default.
- W2110379660 cites W2064397126 @default.
- W2110379660 cites W2064887457 @default.
- W2110379660 cites W2079200242 @default.
- W2110379660 cites W2090403451 @default.
- W2110379660 cites W2097885652 @default.
- W2110379660 cites W2099833638 @default.
- W2110379660 cites W2101282109 @default.
- W2110379660 cites W2105376855 @default.
- W2110379660 cites W2107820540 @default.
- W2110379660 cites W2111845136 @default.
- W2110379660 cites W2114613490 @default.
- W2110379660 cites W2115294836 @default.
- W2110379660 cites W2117134611 @default.
- W2110379660 cites W2119528561 @default.
- W2110379660 cites W2121298241 @default.
- W2110379660 cites W2130735976 @default.
- W2110379660 cites W2136332296 @default.
- W2110379660 cites W2137944397 @default.
- W2110379660 cites W2138215265 @default.
- W2110379660 cites W2147691334 @default.
- W2110379660 cites W2154569902 @default.
- W2110379660 cites W2154787902 @default.
- W2110379660 cites W2163709153 @default.
- W2110379660 cites W2171539930 @default.
- W2110379660 cites W2171616229 @default.
- W2110379660 doi "https://doi.org/10.1001/archgenpsychiatry.2010.184" @default.
- W2110379660 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3076045" @default.
- W2110379660 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21199965" @default.
- W2110379660 hasPublicationYear "2011" @default.
- W2110379660 type Work @default.
- W2110379660 sameAs 2110379660 @default.
- W2110379660 citedByCount "138" @default.
- W2110379660 countsByYear W21103796602012 @default.
- W2110379660 countsByYear W21103796602013 @default.
- W2110379660 countsByYear W21103796602014 @default.
- W2110379660 countsByYear W21103796602015 @default.
- W2110379660 countsByYear W21103796602016 @default.
- W2110379660 countsByYear W21103796602017 @default.
- W2110379660 countsByYear W21103796602018 @default.
- W2110379660 countsByYear W21103796602019 @default.
- W2110379660 countsByYear W21103796602020 @default.
- W2110379660 countsByYear W21103796602021 @default.
- W2110379660 countsByYear W21103796602022 @default.
- W2110379660 countsByYear W21103796602023 @default.
- W2110379660 crossrefType "journal-article" @default.
- W2110379660 hasAuthorship W2110379660A5000921316 @default.
- W2110379660 hasAuthorship W2110379660A5002128677 @default.
- W2110379660 hasAuthorship W2110379660A5004819487 @default.
- W2110379660 hasAuthorship W2110379660A5010114260 @default.
- W2110379660 hasAuthorship W2110379660A5019562259 @default.
- W2110379660 hasAuthorship W2110379660A5034902188 @default.
- W2110379660 hasAuthorship W2110379660A5036815556 @default.
- W2110379660 hasAuthorship W2110379660A5045976176 @default.
- W2110379660 hasAuthorship W2110379660A5047160700 @default.